TrialEuropean journal of drug metabolism and pharmacokinetics2019

Clinical Pharmacokinetics of a Lipid-Based Formulation of Risperidone, VAL401: Analysis of a Single Dose in an Open-Label Trial of Late-Stage Cancer Patients.

Suzanne J Dilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.